Stereotaxis, Inc.

AMEX:STXS

Medical - Instruments & Supplies

Healthcare
$0.95 +2.53%

+$0.05 today

Market cap
$94.80M
Beta
1.32
P/E (TTM)
-8.3
EPS (TTM)
-$0.22
52W Low $1.70High $3.59

Volume 0.90M

Average 0.39M

STXS Total Liabilities

Everything the company owes to creditors and other parties.

Stereotaxis, Inc.AMEX: STXS

Total Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total liabilities falls 8.3% from a year ago

Total liabilities stood at $34.43M at the end of Q1 FY2026, down 8.3% from a year earlier and up 2.7% from the prior quarter. Over 3 fiscal years it compounded at +16.0% a year.

Context

  • Total liabilities amounted to 63.7% of total assets at the end of Q1 FY2026, down 18.4 pp from a year earlier.
  • Total liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether total liabilities keeps falling in the next quarterly balance sheet after a -8.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$34.43M+2.7% QoQ
Last fiscal yearDec 2025
$33.53M-5.0% YoY
Year agoMar 2025
$37.53M-8.3% since
Total Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-8.3%——
1 year-5.0%——
3-year CAGR+16.0%——
5-year CAGR——
10-year CAGR——

Total Liabilities history

USD · from the balance sheet

Latest · FY2025
33.53M USD
Year-over-year change
-5.0%
4-year CAGR
+11.7%

Total Liabilities vs competitors

How STXS compares with its peers on the latest reported figures

  • STXS's Mar 2026 total liabilities of $34.43M is the 4th highest of the 5 companies compared; the peer median is $55.3M.
  • Its year-over-year change of -8.3% is the lowest of 5, against a peer median of +80.7%.
  • Total liabilities amounts to 63.7% of total assets for STXS, versus a peer median of 59.8%.
STXS Competitors Peer median
Total Liabilities for STXS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NPCENeuroPace, Inc.Mar 2026$84.44M -1.7%+2.9%85.4%
CLPTClearPoint Neuro, Inc.Mar 2026$74.58M +639.6%+55.3%79.8%
SSIISS Innovations International, Inc.Mar 2026$36.02M +57.3%+55.1%39.8%
STXSStereotaxis, Inc.Mar 2026$34.43M -8.3%+16.0%63.7%
MBOTMicrobot Medical Inc.Mar 2026$3.96M +104.1%+21.1%5.1%
Peer median (excluding STXS) $55.3M+80.7%+38.1%59.8%

Competitors are the stored peer set for STXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents38.74M8.59M19.82M12.22M13.42M
Short-term Investments019.84M000
Net Receivables5.41M5.09M3.82M3.82M10.16M
Inventory4.43M7.88M8.43M8.33M9.57M
Other Current Assets570K525K623K1.28M698K
Total Current Assets51.39M43.25M33.27M26.44M33.85M
Property, Plant & Equipment (Net)8.37M9.22M8.29M9.06M7.93M
Goodwill0003.76M3.76M
Intangible Assets0007.36M6.43M
Long-term Investments00219K00
Tax Assets00000
Other Non-current Assets1.23M952K137K107K278K
Total Non-current Assets9.6M10.17M8.64M20.29M18.4M
Total Assets60.99M53.41M41.91M46.72M52.25M
Account Payables4.19M3.27M3.19M5.67M4.77M
Short-term Debt00000
Tax Payables177K47K000
Deferred Revenue6.28M7.34M7.7M7.85M6.72M
Other Current Liabilities0163K04.59M4.89M
Total Current Liabilities13.26M14.29M13.25M21.6M22.36M
Long-term Debt00004.79M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)2.24M1.65M1.64M2.06M555K
Other Non-current Liabilities218K51K43K6.19M5.82M
Total Non-current Liabilities8.3M7.19M6.74M13.69M11.17M
Total Liabilities21.56M21.48M19.99M35.29M33.53M
Common Stock75K75K81K85K95K
Retained Earnings(498.68M)(516.97M)(537.68M)(561.73M)(583.37M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity39.43M31.93M21.92M11.43M18.72M
Total Debt6.11M5.86M5.49M6.01M5.44M
Net Debt(32.63M)(2.73M)(14.33M)(6.21M)(7.99M)

Stereotaxis, Inc.

AMEX:STXS

Intrinsic Alpha fair value

Locked

Current Price

$0.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.